DNDN up 50% this morning. That spells good news for us and the rest of this class of drug makers. DNDN is the first and when they hit a snag so does the sector. The last big dip was on their news that they fudged the use of their drug, This AM we get more news of expanded Pancrease use. Maybe it will stick this time.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.